Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic ...

The amount of frozen funds could be as high as $200 million, or potentially more than $300 million, according to two ...

One of the most notable accomplishments of the first Trump Administration was its willingness to take on the status quo of ...

Overall, the initial steps of the wind-down will result the in the cancellation of nearly $500 million. Not all mRNA related ...

An investigation by Sens. Ron Wyden and Elizabeth Warren is another setback for UnitedHealth, which recently laid out a lower ...

This is the online version of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Propel Health Communications, a 2025 MM+M Agency 100 honoree, hired Christopher Thorn as SVP, creative director and Lauren Schulz as SVP of client services. DiaMedica announced the appointment of ...